Marsh & McLennan Companies, Inc.
NYSE:MRSHInsurance - Brokers
-$2.87 today
- Market cap
- $98.03B
- Beta
- 0.61
- P/E (TTM)
- 19.9
- EPS (TTM)
- $8.11
- Dividend yield
- 2.23%
Volume 1.40M
Average 3.00M
MRSH EBITDA Margin
EBITDA as a percentage of revenue.
Marsh & McLennan Companies, Inc.NYSE: MRSH
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin narrows to 22.0%
EBITDA Margin was 22.0% in Q3 FY2026, down 1.1 pp from a year earlier. On a trailing-twelve-month basis it was 21.1%, down 6.6 pp year over year. Over 3 fiscal years it widened by 2.0 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 14 analysts of 26.8% for the fiscal year ending Dec 2026, down from 27.4% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 22.0%+2.8 pp QoQ
- Last fiscal yearDec 2025
- 27.4%-0.9 pp YoY
- LTMSep 2026
- 21.1%-6.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -1.1 pp | +1.0 pp | +2.2 pp |
| 1 year | -0.9 pp | -0.6 pp | +0.3 pp |
| 3 years | +2.0 pp | -0.7 pp | -2.7 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 27.4%
- Year-over-year change
- -0.9pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 27.4% | -0.9pp |
| FY2024 | 2024-12-31 | 28.3% | +0.5pp |
| FY2023 | 2023-12-31 | 27.8% | +2.3pp |
| FY2022 | 2022-12-31 | 25.4% | -1.8pp |
| FY2021 | 2021-12-31 | 27.2% | — |
EBITDA Margin vs competitors
How MRSH compares with its peers on the latest reported figures
- MRSH's LTM Sep 2026 EBITDA Margin of 21.1% is the 6th highest of the 7 companies compared; the peer median is 26.1%.
- Its year-over-year change of -6.6 pp is the 5th highest of 7, against a peer median of -4.7 pp.
- Over three fiscal years its change of +2.0 pp compares with a peer median of +2.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 38.3% | +8.0 pp | +0.5 pp | |
| LTM Sep 2026 | 27.5% | -7.6 pp | +0.4 pp | |
| LTM Jun 2026 | 27.0% | -6.4 pp | +4.6 pp | |
| LTM Jun 2026 | 25.2% | -3.0 pp | +0.7 pp | |
| LTM Jun 2026 | 24.5% | -1.5 pp | +3.5 pp | |
| LTM Sep 2026 | 21.1% | -6.6 pp | +2.0 pp | |
| LTM Sep 2026 | 2.3% | -10.1 pp | +4.0 pp | |
| Peer median (excluding MRSH) | 26.1% | -4.7 pp | +2.1 pp | |
Competitors are the stored peer set for MRSH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 19.82B | 20.72B | 22.74B | 24.46B | 26.98B |
| Cost of Revenue | 11.43B | 12.07B | 13.1B | 14B | 15.58B |
| Gross Profit | 8.4B | 8.65B | 9.64B | 10.46B | 11.4B |
| Gross Margin | 42.4% | 41.7% | 42.4% | 42.8% | 42.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 4.08B | 4.37B | 4.36B | 4.65B | 5.18B |
| Depreciation & Amortization | 747M | 719M | 713M | 746M | 910M |
| EBITDA | 5.4B | 5.27B | 6.32B | 6.93B | 7.4B |
| EBITDA Margin | 27.2% | 25.4% | 27.8% | 28.3% | 27.4% |
| Operating Income | 4.31B | 4.28B | 5.28B | 5.82B | 6.22B |
| Operating Margin | 21.8% | 20.7% | 23.2% | 23.8% | 23.1% |
| Interest Income | 2M | 15M | 78M | 83M | 48M |
| Interest Expense | 444M | 469M | 578M | 700M | 960M |
| Other Income / Expenses | (104M) | (198M) | (256M) | (337M) | (684M) |
| Income Before Tax | 4.21B | 4.08B | 5.03B | 5.48B | 5.54B |
| Pre-Tax Margin | 21.2% | 19.7% | 22.1% | 22.4% | 20.5% |
| Income Tax Expense | 1.03B | 995M | 1.22B | 1.36B | 1.31B |
| Net Income | 3.14B | 3.05B | 3.76B | 4.06B | 4.16B |
| Net Margin | 15.9% | 14.7% | 16.5% | 16.6% | 15.4% |
| EPS (Basic) | 6.20 | 6.11 | 7.60 | 8.25 | 8.48 |
| EPS (Diluted) | 6.13 | 6.04 | 7.53 | 8.18 | 8.43 |
| Weighted Avg Shares | 507M | 499M | 494M | 492M | 487M |
| Weighted Avg Shares (Diluted) | 513M | 505M | 499M | 496M | 490M |
Marsh & McLennan Companies, Inc.
NYSE:MRSH
Intrinsic Alpha fair value
Locked
Current Price
$205.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.